Real-time enrollment status for this idiopathic cd4+ lymphocytopenia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:30 PM UTC
| NCT Number | NCT00867269 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic CD4+ Lymphocytopenia |
| Phase | Clinical Trial |
| Target Enrollment | 950 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | July 16, 2026 (Yesterday) |
As of July 17, 2026: Clinical trial NCT00867269 is currently recruiting participants. This clinical trial study for idiopathic cd4+ lymphocytopenia is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT00867269 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT00867269 was last updated Yesterday (July 16, 2026). HelloStudys verifies this status automatically.